HOYA Corporation (HOCPY)
USD 109.01
(1.78%)
USD 109.01
(1.78%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 260.44 Billion JPY | 28.14% |
| 2022 | 259.78 Billion JPY | 4.63% |
| 2021 | 243.96 Billion JPY | 24.66% |
| 2020 | 200.26 Billion JPY | 12.59% |
| 2019 | 182.09 Billion JPY | 5.89% |
| 2018 | 172.8 Billion JPY | 8.17% |
| 2017 | 157.98 Billion JPY | 12.32% |
| 2016 | 135.62 Billion JPY | -8.11% |
| 2015 | 151.15 Billion JPY | -0.01% |
| 2014 | 139.65 Billion JPY | 23.23% |
| 2013 | 114.58 Billion JPY | 1.63% |
| 2012 | 124.21 Billion JPY | 39.49% |
| 2011 | 88.5 Billion JPY | -11.13% |
| 2010 | 107.79 Billion JPY | 7.07% |
| 2009 | 87.36 Billion JPY | -22.52% |
| 2008 | 120.04 Billion JPY | -17.23% |
| 2007 | 140.88 Billion JPY | 5.59% |
| 2006 | 143.55 Billion JPY | 5.11% |
| 2005 | 130.67 Billion JPY | 22.1% |
| 2004 | 107.02 Billion JPY | 33.49% |
| 2003 | 78.97 Billion JPY | 59.92% |
| 2002 | 48.9 Billion JPY | -15.57% |
| 2001 | 57.84 Billion JPY | 16.84% |
| 2000 | 50.22 Billion JPY | -1.34% |
| 1999 | 51.45 Billion JPY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 69.44 Billion JPY | 14.3% |
| 2023 Q2 | 75.85 Billion JPY | 5.21% |
| 2023 Q4 | 63.89 Billion JPY | 2.35% |
| 2023 FY | - JPY | 28.14% |
| 2023 Q1 | 72.09 Billion JPY | 6.27% |
| 2023 Q3 | 62.42 Billion JPY | -17.7% |
| 2022 FY | - JPY | 4.63% |
| 2022 Q1 | 73.92 Billion JPY | 11.08% |
| 2022 Q2 | 74.53 Billion JPY | 0.82% |
| 2022 Q3 | 52.04 Billion JPY | -30.17% |
| 2022 Q4 | 67.84 Billion JPY | 30.35% |
| 2021 Q1 | 61.88 Billion JPY | 9.12% |
| 2021 Q3 | 63.14 Billion JPY | -2.67% |
| 2021 Q4 | 66.55 Billion JPY | 5.39% |
| 2021 FY | - JPY | 24.66% |
| 2021 Q2 | 64.88 Billion JPY | 4.83% |
| 2020 Q1 | 40.63 Billion JPY | 9.53% |
| 2020 Q3 | 55.63 Billion JPY | 5.47% |
| 2020 Q4 | 56.71 Billion JPY | 1.94% |
| 2020 FY | - JPY | 12.59% |
| 2020 Q2 | 52.75 Billion JPY | 29.83% |
| 2019 Q1 | 45.59 Billion JPY | 15.91% |
| 2019 Q2 | 52.81 Billion JPY | 15.85% |
| 2019 Q3 | 47.22 Billion JPY | -10.58% |
| 2019 Q4 | 37.09 Billion JPY | -21.46% |
| 2019 FY | - JPY | 5.89% |
| 2018 Q3 | 46.27 Billion JPY | 3.26% |
| 2018 Q1 | 42.14 Billion JPY | 7.89% |
| 2018 Q2 | 44.81 Billion JPY | 6.32% |
| 2018 Q4 | 39.33 Billion JPY | -15.0% |
| 2018 FY | - JPY | 8.17% |
| 2017 Q2 | 40.25 Billion JPY | 5.59% |
| 2017 FY | - JPY | 12.32% |
| 2017 Q4 | 39.06 Billion JPY | -7.16% |
| 2017 Q1 | 38.12 Billion JPY | 16.09% |
| 2017 Q3 | 42.08 Billion JPY | 4.53% |
| 2016 Q1 | 30.13 Billion JPY | -4.31% |
| 2016 Q2 | 39.07 Billion JPY | 29.68% |
| 2016 Q3 | 39.98 Billion JPY | 2.32% |
| 2016 FY | - JPY | -8.11% |
| 2016 Q4 | 32.84 Billion JPY | -17.86% |
| 2015 Q2 | 42.92 Billion JPY | 6.1% |
| 2015 FY | - JPY | -0.01% |
| 2015 Q4 | 31.49 Billion JPY | -20.69% |
| 2015 Q3 | 39.7 Billion JPY | -7.49% |
| 2015 Q1 | 40.45 Billion JPY | 17.14% |
| 2014 Q1 | 31.06 Billion JPY | -1.31% |
| 2014 Q2 | 43.33 Billion JPY | 39.53% |
| 2014 FY | - JPY | 23.23% |
| 2014 Q3 | 45.37 Billion JPY | 4.7% |
| 2014 Q4 | 34.53 Billion JPY | -23.88% |
| 2013 FY | - JPY | 1.63% |
| 2013 Q4 | 31.47 Billion JPY | -18.12% |
| 2013 Q3 | 38.43 Billion JPY | 48.31% |
| 2013 Q2 | 25.91 Billion JPY | -12.52% |
| 2013 Q1 | 29.62 Billion JPY | -25.45% |
| 2012 Q4 | 39.74 Billion JPY | 54.48% |
| 2012 Q1 | 33.8 Billion JPY | 32.66% |
| 2012 FY | - JPY | 39.49% |
| 2012 Q2 | 50.05 Billion JPY | 48.09% |
| 2012 Q3 | 25.72 Billion JPY | -48.61% |
| 2011 FY | - JPY | -11.13% |
| 2011 Q1 | 50.08 Billion JPY | 116.85% |
| 2011 Q2 | 48.57 Billion JPY | -3.03% |
| 2011 Q3 | 13.84 Billion JPY | -71.49% |
| 2011 Q4 | 25.48 Billion JPY | 83.99% |
| 2010 Q1 | 25.83 Billion JPY | -2.62% |
| 2010 FY | - JPY | 7.07% |
| 2010 Q4 | 23.09 Billion JPY | -11.77% |
| 2010 Q3 | 26.17 Billion JPY | 8.43% |
| 2010 Q2 | 24.14 Billion JPY | -6.54% |
| 2009 FY | - JPY | -22.52% |
| 2009 Q4 | 26.53 Billion JPY | -4.0% |
| 2009 Q3 | 27.63 Billion JPY | 18.73% |
| 2009 Q2 | 23.27 Billion JPY | 49.23% |
| 2009 Q1 | 15.59 Billion JPY | 0.55% |
| 2008 Q4 | 15.51 Billion JPY | -49.64% |
| 2008 Q3 | 30.8 Billion JPY | -20.24% |
| 2008 Q2 | 38.61 Billion JPY | 10.0% |
| 2008 Q1 | 35.1 Billion JPY | 17.42% |
| 2008 FY | - JPY | -17.23% |
| 2007 Q4 | 29.89 Billion JPY | -30.99% |
| 2007 Q3 | 43.32 Billion JPY | 14.04% |
| 2007 Q1 | 33.81 Billion JPY | 0.0% |
| 2007 Q2 | 37.99 Billion JPY | 12.35% |
| 2007 FY | - JPY | 5.59% |
| 2006 FY | - JPY | 5.11% |
| 2005 FY | - JPY | 22.1% |
| 2004 FY | - JPY | 33.49% |
| 2003 FY | - JPY | 59.92% |
| 2002 FY | - JPY | -15.57% |
| 2001 FY | - JPY | 16.84% |
| 2000 FY | - JPY | -1.34% |
| 1999 FY | - JPY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Medical Technologies Inc. | -963.95 Thousand USD | 27018712.921% |
| Ansell Limited | 209.86 Million USD | -124004.343% |
| Ansell Limited | 206.3 Million USD | -126146.728% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 42.83 Million USD | -607855.658% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -1.62 Million USD | 16028090.998% |
| Psykey, Inc. | -1.29 Million USD | 20107117.349% |
| ConvaTec Group Plc | 455.5 Million USD | -57078.266% |
| ConvaTec Group Plc | 455.5 Million USD | -57078.266% |
| Encision Inc. | -544.19 Thousand USD | 47859231.378% |
| Golden Valley Development, Inc | -141.81 Thousand USD | 183659221.36% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | 236920867.761% |
| Innovative MedTech Inc. | -7.67 Million USD | 3394069.39% |
| LifePoint, Inc. | -14.2 Million USD | 1833957.82% |
| Medite Cancer Diagnostics, Inc. | -6.18 Million USD | 4209684.613% |
| Paradigm Medical Industries, Inc. | -325 Thousand USD | 80137638.462% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -215.23 Thousand USD | 121006539.503% |
| Reflect Scientific, Inc. | -405.78 Thousand USD | 64183754.358% |
| SmileDirectClub, Inc. | -186.13 Million USD | 140020.704% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 447.82 Million USD | -58058.29% |
| SheerVision, Inc. | -110.53 Thousand USD | 235632637.478% |
| United Health Products, Inc. | -2.5 Million USD | 10408762.089% |
| Vasamed, Inc. | -4.57 Million USD | 5693625.024% |
| Wearable Health Solutions, Inc. | -2.26 Million USD | 11520551.747% |
| Yubo International Biotech Limited | -1.17 Million USD | 22115247.841% |